Last updated on September 2018

Evaluation of SPN-812 ER High Dose in Adolescents With ADHD

Brief description of study

This study will evaluate the efficacy and safety of high doses of SPN-812 ER in adolescents (12-17 years old).

Clinical Study Identifier: TX211879

Contact Investigators or Research Sites near you

Start Over

Colleen Figueroa

University of South Florida-Morsani College of Medicine
Tampa, FL USA
  Connect »